MabThera 500 mg concentrate for solution for infusion, Polivy 140 mg powder for concentrate for solution for infusion., GEMCITABINE , OXALIPLATIN
MO40598
Phase 3 small_molecule active
Quick answer
MabThera 500 mg concentrate for solution for infusion, Polivy 140 mg powder for concentrate for solution for infusion., GEMCITABINE , OXALIPLATIN for Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active